Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Auto Physical Damage
News Release
Aviva Canada Selects Mitchell Solutions to Help Streamline Claims Management
SAN DIEGO, Calif.— Mitchell, an Enlyte company and leading technology and information provider for the
Workers' Comp
White Paper
Unlocking the DME “Black Box”
Mitchell
News Release
CDC Updates and Replaces Guidelines for Prescribing Opioids
The Centers for Disease Control and Prevention (CDC) released an updated and expanded recommendation for clinicians prescribing opioids for outpati
PRIMA
Article
The Impact of Resilience on Recovery from Injury or Illness
Read now
Workers' Comp
Article
Ask The Pharmacist: Traveling With a Controlled Substance Prescription Medication
Are there rules or recommendations for traveling with a controlled substance? If a patient is traveling with a controlled substance
Auto Casualty
Podcast
Trends in Third Party Claims and How to Address Them
Tom Kerr (TK): Enlyte recently released our Annual Tr